WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Thursday reported fiscal fourth-quarter profit of $9.2 million.
The Watertown, Massachusetts-based company said it had profit of 44 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 57 cents per share.
The biotechnology company posted revenue of $51.3 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $56.2 million.
For the year, the company reported profit of $46.4 million, or $2.21 per share. Revenue was reported as $205.2 million.
Enanta Pharmaceuticals shares have decreased 10% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $63.63, a fall of 19% in the last 12 months.